Pretherapy Gallium-67 Scanning in Paediatric Patients with Hodgkin's Disease

Medical Principles and Practice

Volumn 13, Issue 2, 2004, Pages 74-77

  Shah Syed, G M ^a   Younis, M N ^a   Usmani, G N ^b   Zafar, N ^c  

^a KUWAIT UNIVERSITY   (Kuwait)

^b SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

^c NONE

Author keywords

Gallium 67 scanning; Gallium 67 uptake; Hodgkin's disease, subtypes

Indexed keywords

GALLIUM 67;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; SCLEROSIS; SKELETAL MUSCLE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GALLIUM RADIOISOTOPES; HODGKIN DISEASE; HUMANS; INFANT; MALE;

EID: 1042301219     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075632     Document Type: Article

References (15)

1. Jenkin D, Doyle J, Berry M, Blanchette V, Chan H, Doherty M, Freedman M, Greenberg M, Panzarella T, Saunders F, et al: Hodgkin's disease in children: Treatment with MOPP and low-dose, extended field irradiation without laparotomy: Late results and toxicity. Med Pediatr Oncol 1990;18:265-272.
2. Menzel C, Dobert N, Mitrou P, Mose S, Diehl M, Berner U, Grunwald F: Positron emission tomography for the staging of Hodgkin's lymphoma: Increasing the body of evidence in favor of the method. Acta Oncol 2002;41:430-436.
3. Nikpoor N, Aliabadi P, Diaz L, Mannting F: Long-term follow-up of residual mediastinalhilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: What degree of Ga-67 uptake is significant? Clin Nucl Med 2000;25:959-962.
4. Israel O, Front D, Epelbaum R, Ben-Haim S, Jerushalmi J, Kleinhaus U, Even-Sapir E, Robinson E: Residual mass and negative gallium scintigraphy in treated lymphomas. J Nucl Med 1990;31:365-368.
5. Front D, Israel O, Epelbaum R, Ben Haim S, Sapir EE, Jerushalmi J, Kolodny GM, Robinson E: Ga-67 SPECT before and after treatment of lymphoma. Radiology 1990;175:515-519.
6. Front D, Bar-Shalom R, Epelbaum R, Haim N, Ben-Arush MW, Ben-Shahar M, Gorenberg M, Kleinhaus U, Parmett S, Kolodny GM: Early detection of lymphoma recurrence with Ga-67 scintigraphy. J Nucl Med 1993;34:2101-2104.
7. Front D, Israel O: Present state and future role of gallium 67 in lymphoma. J Nucl Med 1996;37:530-532.
8. Flores LG 2nd, Jinnouchi S, Nagamachi S, Ohnishi T, Futami S, Watanabe K: Increased bone marrow uptake of Ga-67 in patients with fever of unknown origin. Clin Nucl Med 1996;21:786-791.
9. 99mTc-GSA. Kaku Igaku 1996;33:935-942.
10. m-HMPAO leukocyte scans better than the naked eye? Nucl Med Commun 1995;16:290-298.
11. Bekerman C, Hoffer PB, Bitran JD: The role of gallium 67 in the clinical evaluation of cancer. Semin Nucl Med 1984;14:296-323.
12. Badshah S, Anwar SM, Saleem M: Evaluation of efficacy of an alternating chemotherapy regimen in childhood Hodgkin's disease with evaluation of acute and chronic toxicity (abstract). Proc 2nd Shaukat Khanum Memorial Cancer Symp, 1995.
13. Nguyen J, Owens J, Vasinrapee P, Spreth M: Ga-67 imaging in bone marrow hyperplasia. Clin Nucl Med 1996;21:404-406.
14. del Val Gomez M, Gallardo FG, Cobo J, Castro-Beiras J: Abnormal gallium-67 skull uptake: A sign of peripheral marrow activation in HIV-positive patients with disseminated mycobacterioses. J Nucl Med 1995;36:2211-2213.
15. Larar GN, Janicek MJ, Kaplan WD: Ga-67 scintigraphy after bone marrow harvest: Significance of 'sacroiliac' asymmetry in the lymphoma patient. Clin Nucl Med 1993;18:126-129.